Bergsland EK - Search Results

1

A phase II study of axitinib in advanced neuroendocrine tumors.

Strosberg JR, Cives M, Hwang J, Weber T, Nickerson M, Atreya CE, Venook A, Kelley RK, Valone T, Morse B, Coppola D, Bergsland EK. Strosberg JR, et al. Among authors: bergsland ek. Endocr Relat Cancer. 2016 May;23(5):411-8. doi: 10.1530/ERC-16-0008. Epub 2016 Apr 14. Endocr Relat Cancer. 2016. PMID: 27080472 Free PMC article. Clinical Trial.

2

Hepatocellular carcinoma.

Bergsland EK, Venook AP. Bergsland EK, et al. Curr Opin Oncol. 2000 Jul;12(4):357-61. doi: 10.1097/00001622-200007000-00013. Curr Opin Oncol. 2000. PMID: 10888422 Review.

3

Shedding old paradigms: developing viruses to treat cancer.

Bergsland EK, Venook AP. Bergsland EK, et al. J Clin Oncol. 2002 May 1;20(9):2220-2. doi: 10.1200/JCO.2002.20.9.2220. J Clin Oncol. 2002. PMID: 11980991 No abstract available.

4

Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancer.

Mehta KR, Nakao K, Zuraek MB, Ruan DT, Bergsland EK, Venook AP, Moore DH, Tokuyasu TA, Jain AN, Warren RS, Terdiman JP, Waldman FM. Mehta KR, et al. Among authors: bergsland ek. Clin Cancer Res. 2005 Mar 1;11(5):1791-7. doi: 10.1158/1078-0432.CCR-04-1418. Clin Cancer Res. 2005. PMID: 15756001

5

Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer.

Ko AH, Hwang J, Venook AP, Abbruzzese JL, Bergsland EK, Tempero MA. Ko AH, et al. Among authors: bergsland ek. Br J Cancer. 2005 Jul 25;93(2):195-9. doi: 10.1038/sj.bjc.6602687. Br J Cancer. 2005. PMID: 15999098 Free PMC article. Clinical Trial.

6

Phase II study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas.

Ko AH, Dito E, Schillinger B, Venook AP, Bergsland EK, Tempero MA. Ko AH, et al. Among authors: bergsland ek. J Clin Oncol. 2006 Jan 20;24(3):379-85. doi: 10.1200/JCO.2005.01.8267. Epub 2005 Dec 12. J Clin Oncol. 2006. PMID: 16344320 Clinical Trial.

7

Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.

Kulke MH, Bergsland EK, Ryan DP, Enzinger PC, Lynch TJ, Zhu AX, Meyerhardt JA, Heymach JV, Fogler WE, Sidor C, Michelini A, Kinsella K, Venook AP, Fuchs CS. Kulke MH, et al. Among authors: bergsland ek. J Clin Oncol. 2006 Aug 1;24(22):3555-61. doi: 10.1200/JCO.2006.05.6762. J Clin Oncol. 2006. PMID: 16877721 Clinical Trial.

8

A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer.

Ko AH, Quivey JM, Venook AP, Bergsland EK, Dito E, Schillinger B, Tempero MA. Ko AH, et al. Among authors: bergsland ek. Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):809-16. doi: 10.1016/j.ijrobp.2007.01.005. Epub 2007 Mar 23. Int J Radiat Oncol Biol Phys. 2007. PMID: 17363191 Clinical Trial.

9

Islet cell carcinoma: neuroendocrine tumors of the pancreas and periampullary region.

Nakakura EK, Bergsland EK. Nakakura EK, et al. Among authors: bergsland ek. Hematol Oncol Clin North Am. 2007 Jun;21(3):457-73; viii. doi: 10.1016/j.hoc.2007.04.005. Hematol Oncol Clin North Am. 2007. PMID: 17548034 Review.

10

Systemic and regional nonsurgical therapy--what is the optimal strategy for metastatic neuroendocrine cancer?

Nakakura EK, Venook AP, Bergsland EK. Nakakura EK, et al. Among authors: bergsland ek. Surg Oncol Clin N Am. 2007 Jul;16(3):639-51, x. doi: 10.1016/j.soc.2007.04.019. Surg Oncol Clin N Am. 2007. PMID: 17606198 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters